
Industrial & Financial Services · NSE / BSE
Entero Healthcare Solutions Limited was founded in 2018 and is a leading distributor of healthcare products in India. Using a technology-driven platform, the company supplies healthcare products to pharmacies, hospitals, and clinics across the country. Key Highlights: Growing Customer Base: Served 39,500+ retail customers in 2021, 64,200+ in 2022, and 81,400+ in 2023. Also served 1,600+ hospitals in 2021, 2,500+ in 2022, and 3,400+ in 2023. Strong Manufacturer Network: Partnered with 1,900+ healthcare product manufacturers, offering access to 64,500+ product SKUs (as of March 31, 2023). Extensive Infrastructure: Operates 73 warehouses in 37 cities across 19 states and union territories, covering 495 districts in India. Large Workforce: As of March 31, 2023, the company has 3,014 employees across various departments. With its vast distribution network and strong industry relationships, Entero Healthcare Solutions continues to expand its reach in the healthcare sector.
Price Band
₹1195 – ₹1258
Issue Size
₹1600 Cr
Lot Size
11 shares
GMP
+0.2%
Est. Listing
₹1260
at current GMP
Subscribed
1.56x
overall
Open
9 Feb 2024
Close
13 Feb 2024
Allotment
14 Feb 2024
Refund
15 Feb 2024
Demat Credit
16 Feb 2024
Listing
16 Feb 2024
Designated Registrar: Link Intime India Private Limited
Allotment Date
14 Feb 2024
Basis finalization
Refunds Initiate
15 Feb 2024
Mandate release
Demat Credit
16 Feb 2024
Shares in demat
Listing Debut
16 Feb 2024
Trading begins
Entero Healthcare Solutions Limited is bringing an initial public offering (IPO) in the Industrial & Financial Services sector with an aggregate issue size of ₹1,600 Crores. The shares are offered at a price band of ₹1195 to ₹1258 per equity share on NSE and BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2024-02-13, the basis of allotment is scheduled to be finalized on 2024-02-14. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Limited) or the BSE allotment checking window.
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.